New pill hopes to lift postpartum depression in days
NCT ID NCT06963580
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested a new capsule called MI078 in 72 women with postpartum depression. The women took the drug or a placebo for 3 days. Researchers measured depression scores to see if the drug helps symptoms and to find the best dose. The trial is complete, and results will show if MI078 is safe and effective.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- MI078 capsule
- What this could lead to
- If it works, this could point toward a new short-term treatment for postpartum depression.
- What could go wrong
- This is an early Phase 2 trial with only 72 people, so results may not apply to everyone. The drug may not work better than placebo or could have side effects.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POSTPARTUM DEPRESSION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Beijing HuiLongGuan Hospital
Beijing, Beijing Municipality, 100096, China
-
First Affiliated Hospital of Kunming Medical University
Kunming, Yunnan, 650032, China
-
Guangxi Zhuang Autonomous Region People's Hospital
Nanning, Guangxi, 530021, China
-
Linfen Central Hospital
Linfen, Shanxi, 041000, China
-
Shanghai Mental Health Center
Shanghai, Shanghai Municipality, 200122, China
-
Shanghai Pudong New Area Mental Health Center
Shanghai, Shanghai Municipality, 200124, China
-
Shunde Hospital of Southern Medical University
Foshan, Guangdong, 528308, China
-
Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital
Chengdu, Sichuan, 610072, China
-
The Affiliated Beijing Anding Hospital of Capital Medical University, Wuhu Hospital
Wuhu, Anhui, 241000, China
-
The Affiliated Kangning Hospital of Ningbo University
Ningbo, Zhejiang, 315201, China
-
The First Affiliated Hospital of Jinan University
Guangzhou, Guangdong, 510630, China
-
The First Affiliated Hospital of Nanchang University
Nanchang, Jiangxi, 330006, China
-
The First Affiliated Hospital of Ningbo University
Ningbo, Zhejiang, China
-
The First Affiliated Hospital of Wenzhou Medical University
Wenzhou, Zhejiang, 325000, China
-
The First Hospital of Hebei Medical University
Shijiazhuang, Hebei, 050023, China
-
The First Hospital of Shanxi Medical University
Taiyuan, Shanxi, 030001, China
-
The First People's Hospital of Hangzhou
Hangzhou, Zhejiang, 310006, China
-
The People's Hospital of Guizhou Province
Guiyang, Guizhou, 550002, China
-
The Second Affiliated Hospital of Zhejiang University School of Medicine
Hangzhou, Zhejiang, 310009, China
-
Xiamen Xian Yue Hospital
Xiamen, Fujian, China
-
Xingtai People's Hospital
Xingtai, Hebei, 054001, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A single day of online therapy could curb postpartum depression
- Online exercise program aims to revive postpartum sexual health
- A headset for depression in pregnancy — science tests a Drug-Free option
- Treating Mom's depression may help Baby's brain
- Heavy bleeding after birth linked to depression and anxiety risk
- Vitamin B6 could be a simple shield against postpartum depression